We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+14.21%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$987M
AUM Growth
+$120M
Cap. Flow
+$63.5M
Cap. Flow %
6.44%
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$6.71M
2
DXCM icon
DexCom
DXCM
+$6.59M
3
X
US Steel
X
+$6.1M
4
CMBT
CMB.TECH NV
CMBT
+$5.09M
5
SPLK
Splunk Inc
SPLK
+$4.85M

Top Sells

Rank Stock Value
1
GOOS
Canada Goose Holdings
GOOS
+$21.9M
2
STZ icon
Constellation Brands
STZ
+$9.52M
3
LUMN icon
Lumen
LUMN
+$7.13M
4
WY icon
Weyerhaeuser
WY
+$6.3M
5
FDX icon
FedEx
FDX
+$6.07M

Sector Composition

Rank Sector Weight
1 Healthcare 16.75%
2 Technology 15.19%
3 Consumer Discretionary 13.45%
4 Industrials 12.06%
5 Financials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MEDP icon
26
Medpace
MEDP
$16.1B
$3.06M 0.31%
51,973
+3,573
+7% +$213K
CNC icon
27
Centene
CNC
$30.7B
$3.06M 0.31%
57,586
-48,026
-45% -$2.92M
URI icon
28
United Rentals
URI
$67.2B
$3M 0.3%
+26,256
New +$3.24M
HXL icon
29
Hexcel
HXL
$7.79B
$3M 0.3%
+43,369
New +$2.92M
PM icon
30
Philip Morris
PM
$297B
$2.99M 0.3%
33,824
-18,196
-35% -$1.47M
BKNG icon
31
Booking.com
BKNG
$149B
$2.96M 0.3%
42,425
+34,500
+435% +$2.46M
PPLI
32
People Inc
PPLI
$3.09B
$2.88M 0.29%
+76,573
New +$2.83M
SIRI icon
33
SiriusXM
SIRI
$9.98B
$2.87M 0.29%
50,615
+48,349
+2,134% +$2.88M
HUM icon
34
Humana
HUM
$43.7B
$2.77M 0.28%
10,413
+8,130
+356% +$2.34M
CVX icon
35
Chevron
CVX
$392B
$2.76M 0.28%
+22,370
New +$2.65M
MCHP icon
36
Microchip Technology
MCHP
$40.3B
$2.65M 0.27%
+63,944
New +$2.65M
XYZ
37
Block Inc
XYZ
$48.4B
$2.63M 0.27%
35,051
+15,661
+81% +$1.13M
TECH icon
38
Bio-Techne
TECH
$11.2B
$2.62M 0.27%
52,836
+8,800
+20% +$396K
STNG icon
39
Scorpio Tankers
STNG
$3.9B
$2.62M 0.27%
131,880
+9,569
+8% +$181K
EHC icon
40
Encompass Health
EHC
$11B
$2.57M 0.26%
55,270
+25,414
+85% +$1.29M
COLM icon
41
Columbia Sportswear
COLM
$3.04B
$2.54M 0.26%
24,331
+1,595
+7% +$154K
AMGN icon
42
Amgen
AMGN
$208B
$2.52M 0.26%
13,261
+7,094
+115% +$1.35M
AVNT icon
43
Avient
AVNT
$3.33B
$2.47M 0.25%
+84,344
New +$2.65M
AMD icon
44
Advanced Micro Devices
AMD
$776B
$2.46M 0.25%
+96,236
New +$2.18M
DPZ icon
45
Domino's
DPZ
$11.5B
$2.45M 0.25%
+9,506
New +$2.47M
CRL icon
46
Charles River Laboratories
CRL
$11.2B
$2.4M 0.24%
16,500
+659
+4% +$86.6K
COP icon
47
ConocoPhillips
COP
$147B
$2.4M 0.24%
+35,886
New +$2.41M
EMN icon
48
Eastman Chemical
EMN
$8B
$2.37M 0.24%
+31,278
New +$2.49M
CAH icon
49
Cardinal Health
CAH
$53.9B
$2.37M 0.24%
49,202
+23,591
+92% +$1.18M
SBUX icon
50
Starbucks
SBUX
$120B
$2.23M 0.23%
30,009
-11,753
-28% -$808K

Similar funds

GSA Capital Partners's Q1 2019 Portfolio in Review

As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.

  • GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
  • GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
  • GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
  • GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
  • GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
  • GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.

Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.